179 related articles for article (PubMed ID: 8355680)
1. Inducible transcriptional activation of the human immunodeficiency virus long terminal repeat by protein kinase inhibitors.
Brown FL; Tahaoglu E; Graham GJ; Maio JJ
Mol Cell Biol; 1993 Sep; 13(9):5245-54. PubMed ID: 8355680
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
3. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
Murphy KM; Sweet MJ; Ross IL; Hume DA
J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
[TBL] [Abstract][Full Text] [Related]
4. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
5. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
6. An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators.
Li YC; Ross J; Scheppler JA; Franza BR
Mol Cell Biol; 1991 Apr; 11(4):1883-93. PubMed ID: 2005886
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
Maciaszek JW; Talmage DA; Viglianti GA
J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
Roebuck KA; Rabbi MF; Kagnoff MF
AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
Twu JS; Chu K; Robinson WS
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
[TBL] [Abstract][Full Text] [Related]
10. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function.
Kameoka M; Tanaka Y; Ota K; Itaya A; Yoshihara K
Biochem Biophys Res Commun; 1999 Aug; 262(1):285-9. PubMed ID: 10448106
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.
Lacoste J; D'Addario M; Roulston A; Wainberg MA; Hiscott J
J Virol; 1990 Oct; 64(10):4726-34. PubMed ID: 2204723
[TBL] [Abstract][Full Text] [Related]
12. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ
EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080
[TBL] [Abstract][Full Text] [Related]
13. An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
Mallardo M; Dragonetti E; Baldassarre F; Ambrosino C; Scala G; Quinto I
J Biol Chem; 1996 Aug; 271(34):20820-7. PubMed ID: 8702837
[TBL] [Abstract][Full Text] [Related]
14. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
Subler MA; Martin DW; Deb S
J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
[TBL] [Abstract][Full Text] [Related]
15. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
16. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression.
Roebuck KA; Gu DS; Kagnoff MF
AIDS; 1996 Jul; 10(8):819-26. PubMed ID: 8828738
[TBL] [Abstract][Full Text] [Related]
17. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1.
Tesmer VM; Rajadhyaksha A; Babin J; Bina M
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7298-302. PubMed ID: 8346247
[TBL] [Abstract][Full Text] [Related]
18. Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery.
Sakaguchi M; Zenzie-Gregory B; Groopman JE; Smale ST; Kim SY
J Virol; 1991 Oct; 65(10):5448-56. PubMed ID: 1895393
[TBL] [Abstract][Full Text] [Related]
19. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
20. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1.
Demarchi F; D'Agaro P; Falaschi A; Giacca M
J Virol; 1993 Dec; 67(12):7450-60. PubMed ID: 8230466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
